Its interesting the entire announcement seems to sell how...

Its interesting the entire announcement seems to sell how superior and successful Tivan+ is.

But closes with a clause along the lines of: Salt Roasting Versus Tivan+ will be evaluated in Q3 as part of the PFS.

So I guess there is still some cause for concern over the need to invent something new in order to extract value. There may be a perception of this being higher risk to investors? But notably this would also be a higher reward path.

Or just go with the tried and true methodology (salt roasting) to perhaps gain traction quicker using a more traditional sense?

Interesting times ahead.